FY2025 · ended Dec 31, 2025 · Revenue $1.86M, +17.2% YoY · Filed Mar 31, 2026
Vycor Medical, Inc. (VYCO) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $1.9 million and a net loss of $72,426. Free cash flow was -$18,695. As of Jun 30, 2026 it held $158,907 in cash and investments and $26,700 in total debt.
Revenue (TTM)
$1.81M
+1.6% vs year-ago TTM
Net income (TTM)
$-59,930
+26.2% vs year-ago TTM
Operating cash flow (TTM)
$61,384
+859.0% vs year-ago TTM
Free cash flow
$-18,695
-134.1% vs prior year
EPS (TTM)
$-0.01
+5.6% vs year-ago TTM
Dividend per share
None
Shares outstanding
33.37M
+0.0% vs prior year
Net cash
$132,207
as of Jun 30, 2026
Operating margin
2.7%
FY 2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- VYCO (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boca Raton,, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1424768
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $1.9M | $1.6M | $1.5M | $1.2M | $1.4M |
| Operating income | $33,900 | -$9,145 | $40,191 | -$306,514 | -$435,954 |
| Net income | -$72,426 | -$107,200 | -$69,691 | -$404,917 | -$435,662 |
| Diluted EPS | -$0.01 | -$0.01 | -$0.01 | — | — |
| Operating cash flow | -$13,471 | $60,110 | $29,430 | -$217,016 | $21,369 |
| Free cash flow | -$18,695 | $54,744 | $20,044 | -$219,796 | -$17,006 |
| Total assets | $830,420 | $998,117 | $992,298 | $860,178 | $935,364 |
| Total liabilities | $4.9M | $4.7M | $4.3M | $3.8M | $3.3M |
| Stockholders' equity | -$4.1M | -$3.7M | -$3.3M | -$2.9M | $2.4M |
| Cash and investments | $86,982 | $105,648 | $57,291 | $37,035 | $90,941 |
| Total debt | $52,221 | $100,379 | $145,700 | $29,591 | $227,495 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Aug 14, 2026 | Aug 14, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
May 15, 2026 | May 15, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2026 | Mar 31, 2026 |
| 10-K | Annual report | Mar 31, 2026 | Dec 31, 2025 |
All 462 Vycor Medical, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.